4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-107768
Director sold 4,592 shares at an average $35.10 ($161,198)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-09-16 | Sale 10b5-1 | −1,320 | $35.04 | $46,253 | 397,103 | I |
| Kersten Dirk Director | 2024-09-17 | Sale 10b5-1 | −3,272 | $35.13 | $114,945 | 393,831 | I |
| Open-market sales · 4,592 sh · avg $35.10 · $161,198 | |||||||
Loading xslF345X05/ownership.xml…